Skip to main content
|

Add a bookmark to get started

Bookmarks info
Pamela E. Bechtel

Pamela Bechtel Hwang

Of Counsel
San Diego
About

Dr. Pamela Bechtel Hwang's practice focuses on strategic intellectual property counselling, IP portfolio development/management, strategic patent prosecution and IP due diligence for a variety of life science transactions, including venture financings, public offerings, M&A deals and licensing opportunities. Dr. Hwang has technical expertise in molecular biology, immunology, cell biology, biochemistry, regenerative medicine, stem cell technology, immuno-oncology, diagnostics, large and small molecule therapeutics, cell-based therapeutics, gene therapy, CAR-T therapeutics, gene editing technologies, and drug delivery systems.

Dr. Hwang also has experience as an in-house attorney in a biotechnology company prior to joining DLA Piper which provides a unique perspective to her practice.

Areas of FocusPatent Development and Strategy
Bar admissionsCaliforniaUnited States Patent and Trademark Office
Education
  • J.D., University of San Diego School of Law 2007
  • Ph.D., Pharmacology and Toxicology, University of Maryland 1998
  • B.S., Biochemistry, Pennsylvania State University 1993

Bylines

  • US Pat. No. 7,723,487, Method for Purifying Cancer Specific Nuclear Antigen; Malkas, L., Hickey, R., Bechtel, P., Park, M., Hoelz, D., Tomic, D. and Schnaper, L.
  • US Pat. No. 7,294,471, Method for Purifying Cancer Specific Nuclear Antigen; Malkas, L., Hickey, R., Bechtel, P., Park, M., Hoelz, D., Tomic, D. and Schnaper, L.
  • US Pat. No. 7,238,533, Personal Illicit Drug Detection; Legge, R., Hopson, T., Maracas, G., and Bechtel, P.
  • US Pat. App. No. 20080299042, Membrane Associated Molecules, Bechtel, P., Daniels, M., McLachlan, K, Zhai, Y., Colson, B. and O’Brien, N.
  • US Pat. App. No. US 20060073477. Altered DNA Synthesome Components as Biomarkers for Malignancy. Malkas, H., Hickey, R. and Bechtel, P.
  • PCT Pub. No. WO 1999/16469. Altered DNA Synthesome Components as Biomarkers for Malignancy. Malkas, H., Hickey, R., Sekowski, J. and Bechtel, P.

Prior Experience

Before joining DLA Piper, Dr. Hwang worked at Biogen Idec, Inc. for seven years as a patent agent and patent attorney. She also worked at Biogen Idec for two years as a scientist in the Molecular Oncology department. Prior to working at Biogen Idec, Dr. Hwang worked for two years at Motorola Life Sciences in the Protein Microarray group.

Memberships And Affiliations

  • Association of Corporate Counsel
  • California Bar Association
  • American Bar Association
  • American Intellectual Property Association
  • San Diego Intellectual Property Association

My latest insights

News

DLA Piper advises CONMED Corporation in its US$145 million acquisition of In2Bones Global,...

23 May 2022 .2 minute read

Connect

Phone

+1 858 677 1473
(Work, San Diego)
CallvCardLinkedInPrint
Privacy policyYour privacy choicesLegal noticesCookie policyFraud AlertMake a paymentSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2024 DLA Piper US